virus
exhibit
rapid
mutat
capac
trick
infect
host
cell
sometim
assist
viruscod
peptid
counteract
host
cellular
immun
defens
although
larg
number
compound
identifi
inhibit
variou
viral
infect
diseas
progress
urgent
achiev
discoveri
effect
agent
furthermor
proport
great
varieti
diseas
caus
virus
viral
vaccin
avail
effici
thu
new
antivir
substanc
obtain
natur
product
prospect
includ
deriv
venom
anim
venom
complex
mixtur
hundr
molecul
mostli
peptid
present
larg
array
biolog
activ
evolv
put
target
biochem
machineri
differ
pathogen
host
cellular
structur
addit
nonvenom
compound
bodi
fluid
invertebr
organ
exhibit
antivir
activ
review
provid
panorama
peptid
describ
anim
venom
present
antivir
activ
therebi
reinforc
import
tool
develop
new
therapeut
drug
consid
common
patholog
human
anim
cardiovascular
infecti
diseas
cancer
among
lead
caus
death
cultur
educ
background
affect
peopl
larg
influenc
prevent
treatment
human
diseas
nevertheless
avail
new
drug
contribut
greatli
mitig
diseas
virus
known
caus
human
diseas
present
high
public
health
import
cytomegaloviru
cmv
epsteinbarr
viru
ebv
hepat
b
c
virus
hbv
hcv
respect
herp
simplex
viru
hsv
human
immunodefici
viru
hiv
rabi
viru
ebola
viru
recent
worldwid
estim
present
world
health
organ
report
million
death
caus
hiv
million
peopl
live
hepat
b
c
liver
cancer
death
caus
hepat
virus
thousand
case
cervic
cancer
caus
hpv
infect
thousand
cervic
cancer
death
year
antivir
drug
commerci
avail
induc
sever
consider
advers
effect
especi
patient
receiv
lifelong
treatment
diseas
hiv
furthermor
virus
possess
rapid
mutat
capac
trick
infect
host
cell
fact
togeth
propel
prospect
new
antivir
drug
particularli
natur
product
constitut
new
drug
prototyp
approv
last
decad
among
sourc
natur
product
anim
venom
reveal
great
potenti
drug
discoveri
despit
harm
action
mechan
anim
venom
compon
hold
potenti
medicin
properti
cure
diseas
wide
report
literatur
anim
venom
rich
sourc
antimicrobi
substanc
contain
vast
array
activ
biolog
compound
distinct
chemic
structur
thu
antimicrobi
peptid
amp
diversifi
group
peptid
exert
essenti
function
innat
immun
host
respons
invad
pathogen
organ
bacteria
fungi
virusar
consid
first
line
defens
mani
organ
includ
plant
insect
bacteria
vertebr
peptid
exhibit
direct
virucid
activ
other
disturb
attach
viru
particl
cell
membran
surfac
interfer
viru
replic
limit
effici
commonli
use
drug
emerg
resist
virus
antivir
peptid
may
potenti
develop
put
therapeut
agent
addit
reduc
market
avail
collater
effect
toxic
synthet
antivir
drug
trigger
expand
search
natur
compound
display
antivir
activ
compound
util
antivir
compli
viru
pathway
cellular
infecti
cycl
initi
rna
dna
viru
envelop
express
glycoprotein
respons
interact
surfac
molecul
receptor
usual
glycosyl
protein
integr
host
cell
membran
step
potenti
antivir
candid
must
compet
cell
receptor
inhibit
viru
attach
cell
membran
therebi
abort
viral
infect
candid
may
act
intracellularli
interact
virion
capsid
prevent
decapsid
therefor
viral
nucleic
acid
would
freed
transcrib
concern
retrovirus
antivir
candid
act
inhibit
viral
revers
transcriptas
activ
ii
preintegr
complex
thu
avoid
transport
circular
viral
dna
nucleu
iii
also
inhibit
action
viral
integras
would
allow
viral
dna
integr
cellular
chromosom
provir
dna
transcript
transduc
polyprotein
requir
viral
proteas
order
gener
small
protein
assembl
viral
capsid
manner
antivir
compound
could
inhibit
viral
proteas
block
retrovir
morphogenesi
fig
retrovir
protein
play
major
role
pathogenesi
regul
mhc
molecul
host
cell
drive
proteasom
degrad
suppos
antivir
candid
target
viral
protein
nef
tat
vpr
action
restrain
mention
mechan
directli
perform
retrovir
molecul
mechan
could
also
trigger
involv
innat
immun
system
eg
induct
tolllik
receptor
express
interact
fig
action
mechan
anim
venom
peptid
deriv
differ
retroviru
replic
cycl
phase
chtx
scyllatoxinbas
mimet
inhibit
attach
viral
glycoprotein
host
cell
receptor
peptid
cecropin
magainin
papuamid
dermaseptin
caerin
macul
disintegr
viral
envelop
peptid
polyphemusin
tachyplesin
immunokin
obstruct
interact
viral
gp
coreceptor
peptid
miramid
ah
inhibit
fusion
viral
envelop
host
cell
membran
peptid
melittin
didemni
b
c
interfer
revers
transcript
process
abort
synthesi
doublestrand
viral
dna
peptid
hecat
tvslao
act
posttransl
process
cleavag
gagpol
protein
precursor
thu
interf
assembl
viral
capsid
organ
polymeras
complex
viral
nucleic
acid
ii
product
cytokin
stimul
action
cytotox
cell
nk
cell
even
host
cell
express
major
histocompat
complex
molecul
order
present
viral
peptid
cell
immun
system
furthermor
antivir
compound
may
activ
innat
restrict
factor
code
host
cell
viral
dna
integr
host
cell
chromosom
repres
major
problem
overcom
retrovir
infect
avail
drug
capabl
complet
clear
viru
host
furthermor
silent
retrovir
infect
hidden
anatom
site
difficult
reach
drug
gutassoci
lymphoid
tissu
lymph
node
central
nervou
system
infect
cell
includ
macrophag
quiescent
tissu
known
activ
releas
new
viral
progeni
anoth
challeng
antivir
candid
pose
mutat
rate
viral
gene
mainli
among
rna
viru
due
polymeras
synthesi
error
much
intrigu
among
retrovirus
initi
virion
genom
maintain
quiescent
cell
sanctuari
nich
distinct
mutat
round
cell
infect
thu
cycl
viral
infect
hijack
cell
produc
grow
number
recombin
new
virion
arachnid
venom
util
tool
defens
attack
kill
immobil
prey
feed
possibl
competitor
predat
compos
rich
molecular
divers
complex
mixtur
intric
protein
peptid
express
mechan
gene
regul
still
investig
scorpion
venom
exhaust
studi
mainli
due
clinic
effect
envenom
human
sometim
lead
death
paradox
biotechnolog
applic
devis
increas
understand
action
mechan
venom
compon
therefor
mani
research
work
deal
gener
new
drug
base
structur
function
molecul
found
venom
rapid
increas
number
character
scorpion
venom
compound
mani
new
drug
candid
identifi
potenti
medicin
deal
emerg
medic
global
threat
scorpion
biolog
activ
peptid
classifi
disulfidebridg
peptid
dbp
nondisulfidebridg
peptid
ndbp
former
main
compon
scorpion
venom
respons
neurotox
symptom
sign
observ
scorpion
usual
dbp
target
ion
channel
excit
nonexcit
cell
membran
properti
make
molecul
interest
prototyp
drug
treatment
divers
diseas
particularli
affect
neural
system
relat
activ
scorpion
venom
compound
retrovirus
hivsiv
report
dbp
bind
hiv
glycoprotein
due
molecular
mimicri
lentivirus
host
cell
receptor
result
abolish
interact
essenti
initi
conform
chang
viral
envelop
trigger
viral
entri
host
cell
mimet
scorpion
toxin
contain
amino
acid
residu
three
four
disulfid
bridg
character
cysteinestabil
motif
two
peptid
resembl
cdr
loop
charybdotoxin
chtx
scyllatoxin
isol
leiuru
quinquestriatu
hebraeu
venom
present
motif
capabl
block
k
channel
toxin
use
effect
molecular
scaffold
interact
assay
sinc
amino
acid
residu
phe
arg
shown
critic
bind
equival
amino
acid
residu
ad
new
compound
exampl
mimet
peptid
use
chtx
scaffold
includ
amino
acid
residu
respect
among
main
modif
cdr
loop
sequenc
qgsf
insert
equival
posit
chtx
thu
phe
phe
would
function
phe
remain
sequenc
similar
two
analog
except
two
posit
arg
arg
chtx
replac
ly
gli
ntermin
residu
place
val
ser
residu
thu
charg
nterminu
gli
residu
posit
similar
charg
sidechain
arg
abl
inhibit
bind
ic
valu
likewis
also
compet
bind
besid
caus
enhanc
bind
antibodi
subsequ
mimet
exhibit
affin
success
gener
phage
epitop
random
loop
chtxbase
scaffold
scyllatoxin
scaffoldbas
mimet
acid
residu
miniprotein
name
construct
inhibit
bind
ic
valu
structur
function
analysi
perform
suggest
addit
mutat
incorpor
new
compound
caus
increas
affin
ic
valu
depend
viral
strain
addit
inhibit
infect
cell
differ
strain
sequenc
agsf
similar
base
structur
analysi
potent
mimet
bona
fide
properti
synthes
denomin
inhibit
bind
differ
viral
strain
nm
ic
valu
compar
obtain
also
inhibit
cellcel
fusion
infect
cell
express
either
coreceptor
similar
concentr
three
dimension
structur
analyz
complex
anoth
analog
design
denomin
differ
due
presenc
phe
replac
biphenylalanin
posit
bip
author
show
higher
mimicri
addit
present
increas
neutral
isol
phylogenet
relat
primat
lentivirus
scorpion
venom
amp
belong
ndbp
mani
analog
exert
strong
antivir
activ
shown
tabl
compound
act
direct
ruptur
viral
envelop
therebi
decreas
viral
infect
amp
could
also
prevent
block
virion
enter
cell
occupi
cell
receptor
util
viral
glycoprotein
amp
compet
viral
glycoprotein
get
attach
cell
receptor
instead
cross
cell
lipoprotein
membran
intern
cytoplasm
organel
yield
alter
profil
host
cell
enhanc
defens
viru
may
also
block
express
viral
gene
host
cell
halt
viral
dissemin
cell
mucroporin
cation
residu
amp
isol
lycha
mucronatu
venom
one
deriv
name
enhanc
net
posit
charg
besid
antibacteri
activ
present
antivir
activ
measl
sarscov
influenza
virus
tabl
possibl
direct
interact
viru
envelop
addit
shown
reduc
product
hbv
antigen
viral
dna
cell
cultur
microenviron
also
hinder
hbv
infect
mous
model
molecular
mechan
implic
reveal
specif
activ
mitogenactiv
protein
kinas
mapk
lead
downregul
express
consequ
less
bind
hbv
precorecor
promot
region
also
present
activ
amphipath
peptid
screen
cdna
librari
heterometru
petersii
venom
gland
residu
ndbp
inhibit
hcv
infect
tabl
act
viricid
hcv
particl
prevent
initi
hcv
infect
permeabil
viral
envelop
decreas
viru
infect
also
h
petersii
venom
gland
cdna
librari
ndbp
synthes
two
exhibit
potent
virucid
activ
tabl
show
inhibitori
effect
multipl
step
viru
replic
cycl
caus
destruct
viral
morpholog
also
enter
infect
cell
reduc
viral
infect
cdna
librari
mesobuthu
martensii
venom
gland
compound
denomin
amino
acid
residueswa
clone
synthes
base
sequenc
design
make
hcv
hcv
substitut
enhanc
net
posit
charg
structur
compound
exert
activ
inhibit
chemokin
receptor
activ
replic
virus
potent
tabl
anoth
ndbp
screen
chaerilu
tryznai
scorpion
venom
gland
abl
inhibit
initi
hcv
infect
cell
inactiv
infecti
viral
particl
tabl
howev
due
low
bioavail
residu
peptid
could
suppress
establish
infect
thu
order
enhanc
helic
amphiphil
endosom
escap
peptid
author
design
histidinerich
peptid
base
templat
denomin
effect
hcv
tabl
significantli
reduc
intracellular
viral
product
unlik
analog
reduc
viral
rna
respect
howev
diminish
viral
infect
manner
similar
wildtyp
peptid
recent
antivir
activ
scorpio
mauru
palmatu
androctonu
australi
crude
venom
shown
hcv
present
ic
valu
respect
mauru
palmatu
venom
consid
good
natur
sourc
character
new
antihcv
agent
target
entri
step
sinc
impair
hcv
infect
cell
cultur
intracellularli
virucid
effect
effect
inhibit
metalloproteas
inhibitor
heat
snake
venom
compos
mixtur
protein
peptid
free
amino
acid
nucleotid
lipid
carbohydr
metal
element
coupl
protein
studi
report
antivir
activ
snake
venom
compon
measl
viru
sendai
viru
dengu
viru
denv
yellow
fever
viru
yfv
hiv
thu
snake
venom
sourc
promis
candid
new
antivir
drug
tabl
relat
antiretrovir
activ
benefit
treat
patient
multidrugresist
hiv
snake
venom
prepar
addit
antiretrovir
therapi
demonstr
clinic
practic
respons
decreas
viral
load
elev
cell
count
author
suggest
activ
may
relat
presenc
snake
venom
molecul
homolog
glycoprotein
proteas
homolog
occur
highli
conserv
amino
acid
residu
snake
venom
neurotoxin
long
loop
sequenc
short
segment
result
may
compet
receptor
bind
site
present
antihiv
activ
sequenc
homolog
hiv
snake
neurotoxin
cobratoxin
bungarotoxin
gener
antiretrovir
patent
link
fragment
hiv
peptid
fusion
inhibitor
fragment
ectodomain
shown
improv
antihiv
efficaci
besid
structur
homolog
action
mechan
snake
venom
hiv
also
discuss
literatur
catalyticinhibitori
activ
enzym
bind
interfer
receptorenzym
inductioninteract
membran
level
lamino
acid
oxidas
laao
lao
constitut
one
studi
main
compon
snake
venom
oxidoreductas
flavoenzym
molecular
mass
around
kda
usual
noncoval
link
homodimer
glycoprotein
compound
wide
distribut
organ
play
import
role
biolog
activ
apoptosi
induct
cytotox
inhibit
induct
platelet
aggreg
hemorrhag
hemolysi
edema
well
antihiv
antimicrobi
antiparasit
activ
tsvlao
character
trimeresuru
stejnegeri
snake
venom
seem
first
snake
venom
lao
report
present
antivir
activ
tabl
tsvlao
glycoprotein
molecular
weight
kda
also
form
homodim
similarli
lao
snake
venom
precursor
sequenc
obtain
cdna
analysi
code
polypeptid
amino
acid
residu
includ
potenti
signal
peptid
ident
lao
snake
speci
tsvlao
inhibit
infect
replic
dosedepend
manner
seem
act
nanomolar
concentr
inhibit
syncytium
format
ec
nm
antigen
express
ec
nm
addit
anoth
lao
isol
bothrop
jararaca
venom
denomin
bjarlaaoi
tabl
reduc
viral
load
cell
infect
dengu
viru
type
strain
expos
toxin
comparison
control
cdnadeduc
sequenc
amino
acid
residu
similar
snake
venom
lao
flavoenzym
also
produc
hydrogen
peroxid
h
free
radic
appear
enhanc
antivir
activ
compound
found
snake
venom
exhibit
antivir
activ
phospholipas
pla
among
biolog
effect
seem
interact
host
cell
prevent
intracellular
releas
viru
capsid
protein
suggest
block
viral
entri
cell
virion
uncoat
pla
isol
crotalu
durissu
terrificu
venom
pla
cdt
hiv
human
immunodefici
viru
hsv
herp
simplex
viru
iav
influenza
viru
vsv
vesicular
stomat
viru
denv
dengu
viru
adapt
jenssen
et
al
mulder
et
al
inhibit
denv
yfv
vero
cell
pla
part
crotoxin
heterodimer
protein
compos
two
differ
subunit
noncoval
link
basic
pla
kda
acid
protein
crotapotin
kda
mechan
propos
pla
cdt
antivir
activ
involv
cleavag
glycerophospholipid
viru
envelop
protein
destabil
virion
surfac
partial
expos
genom
rna
culmin
viral
inactiv
make
unabl
access
cell
receptor
pla
cdt
also
show
vitro
activ
hiv
tabl
well
snake
venom
pla
nmmcm
iii
naja
mossambica
mossambica
taipoxin
oxyuranu
scutellatu
nigexin
naja
nigricolli
addit
pla
variant
denomin
blkpla
bldpla
bothrop
leucuru
venom
tabl
reduc
dengu
viral
rna
cell
treat
compound
present
cytotox
activ
denvinfect
cell
vitro
blkpla
bldpla
amino
acid
residu
respect
includ
seven
disulfid
bond
anoth
exampl
antivir
effect
biomolecul
extract
snake
venom
metalloproteas
inhibitor
could
prevent
product
new
hiv
particl
inhibit
viral
proteas
addit
oxo
chemi
thailand
oxid
deriv
extract
naja
siamensi
venom
tabl
shown
inhibit
infect
lymphocyt
hiv
chemokin
receptor
mani
report
detail
potent
antivir
activ
amphibian
skin
secret
skin
secret
constitut
amphibian
first
line
defens
consist
innat
immun
secret
produc
anuran
skin
granular
gland
screen
mani
biolog
activ
includ
antimicrobi
antineoplast
antivir
contracept
anthelminth
activ
dermaseptin
famili
antimicrobi
peptid
compris
amino
acid
exhibit
linear
polycation
molecul
dispos
amphiphil
structur
associ
lipid
cell
bilay
bergaoui
et
al
describ
dermaseptin
chemic
synthes
drug
deriv
amphibian
skin
antimicrobi
peptid
exhibit
antiherpet
activ
hsv
type
reduc
cytotox
effect
biochem
modif
origin
peptid
also
reduc
vitro
infect
establish
cell
line
express
cell
receptor
primari
lymphocyt
capabl
act
tropic
virion
upon
insert
viral
envelop
dermaseptin
disrupt
virion
caerin
caerin
maculatin
peptid
also
deriv
skin
secret
amphibian
litoria
caerulea
litoria
chlori
litoria
genimaculata
respect
complet
abolish
hiv
infect
cell
minut
virion
exposur
modifi
peptid
disintegr
viral
envelop
prevent
viral
fusion
cell
membran
furthermor
molecul
obstruct
viral
transfect
dendrit
cell
cell
caerin
peptid
compos
amino
acid
residu
structur
includ
four
central
amino
acid
residu
present
maculatin
peptid
lipid
bilay
membran
peptid
adjust
two
interlink
flexibl
hing
region
limit
pro
pro
determin
disrupt
viral
envelop
cell
membran
mastoparan
tetradecapeptid
present
wasp
vespula
lewisii
venom
form
amphipath
helic
structur
insert
lipid
bilay
bacteria
erythrocyt
mast
cell
other
form
pore
mastoparan
analogu
display
wide
spectrum
antivir
activ
envelop
virus
five
differ
famili
rhabdovirida
poxvirida
flavirida
paramyxovirida
herpesvirida
vitro
assay
tabl
structur
studi
indic
pore
format
insert
mastoporan
amphiphil
helix
viral
lipid
envelop
caus
disrupt
hiv
virion
usual
infect
host
cell
genit
mucosa
infect
macrophag
denomin
mtropic
viru
migrat
lymph
node
infect
lymphocyt
chang
ttropic
viru
base
hiv
tropism
phospholipas
bee
venom
bvpla
block
replic
ttropic
hiv
virion
small
peptid
deriv
bvpla
exclus
inhibit
replic
ttropic
viru
behav
ligand
coreceptor
tabl
amp
isol
invertebr
organ
present
augment
antivir
activ
human
diseas
peptid
enclos
melittin
cecropin
alloferon
molecul
tabl
melittin
isol
honey
bee
api
mellifera
venom
amphipath
peptid
compos
amino
acid
residu
arrang
two
helic
segment
insert
nanoparticl
melittin
exhibit
virucid
activ
cell
line
epitheli
vagin
cell
line
also
inhibit
hiv
infect
tzmbl
report
cell
hela
cell
line
express
hiv
receptor
among
antiretrovir
mechan
melittin
complement
azidovudin
revers
transcript
inhibit
hecat
analogu
melittin
select
reduc
protein
biosynthesi
virusspecifi
glycoprotein
b
c
h
hsv
type
mechan
similar
one
detect
among
infect
lymphoblast
cell
previous
treat
melittin
intervent
process
gagpol
protein
precursor
therefor
specif
intracellular
event
target
melittin
deriv
cecropin
isol
mostli
hemolymph
infect
pupa
silk
moth
hyalophora
cecropia
also
insect
tunic
ascari
nematod
famili
amp
contain
amino
acid
residu
arrang
two
amphiphil
link
glypro
hing
synthet
hybrid
peptid
name
cecropin
magainin
exhibit
potent
antivir
activ
mechan
mainli
base
compound
hydrophob
content
inhibit
virushost
cell
fusion
tabl
alloferon
peptid
constitut
amino
acid
residu
isol
hemolymph
blowfli
calliphora
vicina
alloferon
exert
immunomodulatori
activ
control
infect
human
influenza
viru
mice
model
lethal
pulmonari
infect
wherea
deriv
also
inhibit
vitro
hsv
replic
vero
cell
tabl
peptid
also
display
relev
role
innat
immun
consid
prospect
peptid
pharmaceut
industri
sea
organ
also
promis
sourc
antivir
cation
peptid
present
broad
spectrum
antivir
activ
one
singl
peptid
may
present
activ
differ
virus
pathogen
promiscu
antifreez
pamap
peptid
consist
compos
amino
acid
residu
isol
polar
fish
pleuronect
americanu
tabl
pamap
exert
antimicrobi
activ
bacteria
fungi
neoplast
cell
also
interact
viral
envelop
hsv
type
inhibit
infect
suscept
cell
spong
speci
contain
linear
cyclic
bioactiv
peptid
compos
atyp
amino
acid
residu
gener
uniqu
structur
rare
found
terrestri
organ
compound
particularli
cyclic
depsipeptid
mirabamid
ah
isol
siliquaria
spongia
mirabili
stelletta
clavosa
obstruct
virion
entri
tzmbl
cell
thu
neutral
viral
glycoprotein
fusion
express
hiv
cell
receptor
tabl
peptid
concentr
nm
suffici
inhibit
infect
ic
anoth
cyclodepsipeptid
homophymin
obtain
homophymia
sp
confer
cell
protect
nm
concentr
infect
vitro
tabl
discov
earli
didemnin
b
c
caribbean
tunic
trididemnum
solidum
first
antivir
marin
depsipeptid
describ
didemnin
effect
vaccinia
viru
hsv
type
coxsacki
viru
equin
rhinoviru
present
strong
activ
low
dose
furthermor
peptid
activ
vivo
assay
rat
model
infect
herp
simplex
viru
reduc
skin
lesion
topic
administr
didemnin
inhibit
protein
dna
rna
synthesi
cell
protein
synthesi
inhibit
mechan
may
relat
bind
didemnin
elong
factor
alpha
alpha
didemnin
b
underw
phase
ii
clinic
trial
present
low
select
therapeut
index
well
toxic
side
effect
dehydrodidemnin
b
pharma
mar
sa
spain
current
phase
iii
clinic
trial
anticanc
drug
multipl
myeloma
tcell
lymphoma
sever
antivir
peptid
depsipeptid
describ
marin
spong
genu
theonella
sp
koshikamid
f
h
isol
swinhoei
cupola
papuamid
b
theopapuamid
theonella
sp
swinhoei
respect
inhibit
hiv
entri
cell
theopapuamid
b
isol
indonesian
spong
siliquariaspongia
mirabili
also
abl
inhibit
entri
host
cell
papuamid
present
antivir
activ
also
vesicular
stomat
viru
amphotrop
murin
leukemia
viru
due
tyrosin
residu
presenc
hydrophob
tail
peptid
may
insert
viral
membran
caus
ruptur
peptid
marin
spong
inhibit
entri
host
cell
callipeltin
isol
spong
genu
callipelta
display
antivir
activ
high
select
index
viru
host
cell
si
ratio
cytotox
dose
cd
ed
celebesid
ac
siliquariaspongia
mirabili
neamphamid
neamphiu
huxleyi
compound
structur
similar
callipeptin
papuamid
exhibit
low
toxic
host
cell
select
index
microspinosamid
isol
sidonop
microspinosa
marin
arthropod
speci
also
yield
antivir
peptid
tachyplesin
polyphemusin
shown
activ
attach
chemokin
receptor
also
viral
cell
coreceptor
hemocyt
horsesho
crab
tachypleu
tridentatu
limulu
polyphemu
abund
sourc
tachyplesin
polyphemusin
tachyplesin
consist
amino
acid
residu
primarili
arrang
three
tandem
repeat
tetrapeptid
hydrophob
amino
acidcysaromat
amino
acidarg
amid
cterminu
polyphemusin
analog
compos
amino
acid
residu
expos
antiparallel
conform
stabil
disulfid
bridg
cy
cy
consequ
scarciti
new
famili
antivir
drug
pharmaceut
compani
strengthen
effort
increas
develop
known
current
drug
result
littl
even
improv
exist
therapi
new
patent
protect
guarante
right
stakehold
charg
high
consum
price
due
lack
competit
time
grow
demand
new
drug
natur
therapeut
product
matter
extrem
necess
face
emerg
multiresist
viral
pathogen
compound
obtain
vertebr
invertebr
organ
present
vitro
vivo
antivir
activ
although
none
yet
launch
market
antivir
drug
present
chemic
structur
complet
differ
current
drug
use
therapi
despit
act
similar
target
compound
may
lead
new
class
therapeut
drug
addit
chemic
pharmacolog
studi
emerg
reemerg
virus
medic
relev
challeng
health
author
around
planet
viral
vaccin
taken
long
design
approv
human
anim
util
even
case
could
develop
prevent
cur
measur
alway
hand
health
author
ensur
control
epidem
recent
ebola
viru
africa
arbovirus
particularli
brazilrepres
dengu
chikungunya
zika
virusesor
worldwid
pandem
influenza
hiv
therefor
prospect
screen
phase
biolog
activ
valid
clinic
develop
anim
peptid
repres
essenti
scientif
invest
protect
perpetu
humankind
